In the wake of Medtronic Inc.’s .  for Covidien PLC, analysts at Bernstein are telling investors to expect more deals in the medical-device industry in coming months.. Slower growth, pricing pressures and the overhaul of the U.S. health-care system are driving deals like Medtronic’s Covidien takeover and other recent acquisitions, including Zimmer Holdings Inc.’s .  in April to purchase Biomet Inc. for $13 billion.